Research synthesisModerate evidenceModerate effect11 studies · 8 beneficial · 3 neutral · 0 harmful
Across 11 studies, 8 reported beneficial effects of turmeric/curcumin on pain, predominantly of moderate size, while 3 were neutral and none were harmful. Statistically significant findings were observed in 8 studies, with effects typically observed at 8–12 weeks (median study duration 90 days across 3 reporting studies). The most studied populations include adults with knee osteoarthritis, chronic lower back pain, rheumatoid arthritis, and oral pain conditions, with doses ranging from 170 mg/day to 600 mg twice daily.
- Effective dose range: 170 mg/day to 600 mg twice daily
- Studied populations: adults with knee osteoarthritis, chronic lower back pain, rheumatoid arthritis, oral pain conditions (e.g., recurrent aphthous stomatitis, oral submucous fibrosis, mucositis), and carpal tunnel syndrome
Caveats: Available evidence is overwhelmingly positive (8 of 11 studies beneficial) — clinical literature in this area is subject to publication bias (null-result studies are less likely to be published or indexed). The dose range is wide and not all studies reported exact dosing; effects may vary by formulation (e.g., curcumin vs. turmeric extract). Three neutral studies (including a 2017 meta-analysis and a small 2025 hand OA RCT) suggest benefit may not be consistent across all pain conditions or populations. Most studies were meta-analyses or systematic reviews with moderate-to-low quality of evidence due to small sample sizes or heterogeneity.
Generated Jun 15, 2026